Atea Pharmaceuticals, Inc.
AVIR · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Lucidi Bruno: Form 4
Insider disclosure · Filed · Report period 18 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001593899 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- AVIR on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 225 Franklin Street, Suite 2100, Boston, MA, 02110
- Incorporated in
- MA
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields